Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Barry Uretsky

Concepts (776)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Percutaneous Coronary Intervention
97
2024
300
22.590
Why?
Coronary Occlusion
58
2023
78
13.020
Why?
Coronary Artery Disease
41
2024
278
12.860
Why?
Fractional Flow Reserve, Myocardial
39
2023
126
11.670
Why?
Angioplasty, Balloon, Coronary
55
2020
137
11.150
Why?
Coronary Angiography
114
2023
359
8.890
Why?
Stents
54
2023
350
8.800
Why?
Coronary Vessels
37
2024
164
7.830
Why?
Coronary Stenosis
22
2021
99
6.330
Why?
Myocardial Infarction
52
2024
403
5.390
Why?
Drug-Eluting Stents
22
2023
93
5.000
Why?
Treatment Outcome
128
2024
5285
4.700
Why?
Cardiac Catheterization
34
2023
223
4.150
Why?
Heart Failure
56
2021
528
3.160
Why?
Coronary Artery Bypass
19
2022
122
3.110
Why?
Humans
328
2024
50516
2.980
Why?
Acute Coronary Syndrome
8
2022
76
2.910
Why?
Chronic Disease
55
2023
574
2.460
Why?
Tomography, Optical Coherence
8
2018
107
2.330
Why?
Coronary Disease
26
2015
152
2.260
Why?
Saphenous Vein
14
2021
63
2.250
Why?
Risk Factors
76
2023
3723
2.170
Why?
Graft Occlusion, Vascular
13
2021
74
2.140
Why?
Platelet Aggregation Inhibitors
12
2014
174
2.120
Why?
Coronary Thrombosis
9
2020
25
2.080
Why?
Male
190
2024
25913
2.020
Why?
Myocardial Ischemia
13
2020
114
1.830
Why?
Cardiology
14
2019
91
1.810
Why?
Predictive Value of Tests
27
2023
930
1.800
Why?
Registries
33
2023
563
1.780
Why?
Aged
103
2023
9743
1.770
Why?
Middle Aged
145
2024
12613
1.770
Why?
Coronary Restenosis
8
2021
31
1.710
Why?
Thrombosis
11
2018
250
1.700
Why?
Myocardium
20
2013
445
1.640
Why?
Time Factors
53
2023
2935
1.600
Why?
Heptanoic Acids
15
2008
34
1.550
Why?
Pyrroles
15
2008
68
1.510
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
13
2022
138
1.440
Why?
Risk Assessment
30
2023
1269
1.430
Why?
Heart Injuries
3
2019
15
1.370
Why?
Female
144
2024
27086
1.370
Why?
Hemodynamics
41
2018
265
1.300
Why?
Cardiac Tamponade
4
2024
27
1.290
Why?
Cardiotonic Agents
23
2019
82
1.290
Why?
Ventricular Function, Left
16
2023
169
1.280
Why?
Myocardial Reperfusion Injury
10
2011
49
1.240
Why?
Postoperative Complications
17
2019
1033
1.150
Why?
Collateral Circulation
10
2020
39
1.150
Why?
Heart Transplantation
30
2009
364
1.120
Why?
Vasodilator Agents
8
2016
100
1.110
Why?
Coronary Circulation
11
2024
59
1.060
Why?
Societies, Medical
10
2019
187
1.050
Why?
Heart-Assist Devices
4
2020
156
1.040
Why?
Contrast Media
9
2018
192
0.980
Why?
Ventricular Dysfunction, Left
8
2018
106
0.970
Why?
Prosthesis Design
11
2021
245
0.970
Why?
Cardiac Catheters
4
2020
12
0.960
Why?
Thrombolytic Therapy
2
2020
110
0.950
Why?
Death, Sudden, Cardiac
6
2008
57
0.920
Why?
Pericarditis
2
2022
20
0.910
Why?
Balloon Occlusion
1
2024
17
0.890
Why?
Adenosine
7
2018
71
0.880
Why?
Algorithms
6
2021
628
0.880
Why?
Pericardial Effusion
1
2024
38
0.870
Why?
Hemorrhage
4
2019
197
0.860
Why?
Digitalis
2
2021
5
0.850
Why?
Cardiovascular Agents
5
2009
55
0.840
Why?
Occupational Health
1
2023
66
0.820
Why?
Aneurysm, False
5
2020
43
0.820
Why?
Pericarditis, Constrictive
1
2022
2
0.820
Why?
Aorta
4
2019
163
0.790
Why?
Retrospective Studies
32
2020
6264
0.790
Why?
Hypotension, Controlled
1
2021
3
0.770
Why?
Radiography, Interventional
7
2018
57
0.760
Why?
Anemia
1
2022
67
0.750
Why?
Angina, Unstable
8
2016
22
0.730
Why?
Thrombocytopenia
1
2022
81
0.730
Why?
Mammary Arteries
3
2017
8
0.730
Why?
Absorbable Implants
2
2022
15
0.720
Why?
Prognosis
19
2023
1977
0.720
Why?
Follow-Up Studies
27
2019
2242
0.720
Why?
Inferior Wall Myocardial Infarction
1
2020
1
0.710
Why?
Thiazolidinediones
6
2008
82
0.700
Why?
Time-to-Treatment
2
2020
73
0.690
Why?
Shock, Cardiogenic
1
2020
25
0.680
Why?
Heart Ventricles
9
2012
265
0.670
Why?
Cardiovascular Diseases
11
2015
460
0.670
Why?
Digoxin
11
2021
29
0.670
Why?
Stroke Volume
18
2023
141
0.660
Why?
Diabetic Angiopathies
2
2013
21
0.660
Why?
Prospective Studies
28
2023
2378
0.650
Why?
Enbucrilate
1
2019
6
0.650
Why?
Tissue Adhesives
1
2019
13
0.650
Why?
Arterial Pressure
1
2019
45
0.650
Why?
Hyperemia
3
2016
18
0.650
Why?
Pericardium
4
2022
28
0.650
Why?
Practice Guidelines as Topic
3
2020
468
0.640
Why?
Operative Time
3
2019
71
0.630
Why?
Guideline Adherence
1
2020
136
0.630
Why?
Adrenergic beta-Antagonists
5
2008
108
0.620
Why?
Aspirin
5
2022
112
0.610
Why?
Hematoma
2
2013
64
0.600
Why?
Troponin T
3
2011
13
0.600
Why?
Severity of Illness Index
19
2019
978
0.590
Why?
Electrocardiography
15
2022
263
0.590
Why?
Heart Septum
3
2010
24
0.590
Why?
Hydrostatic Pressure
1
2017
7
0.580
Why?
Angioplasty, Balloon
4
2022
67
0.560
Why?
Perioperative Care
5
2015
42
0.560
Why?
Angiotensin-Converting Enzyme Inhibitors
10
2011
74
0.560
Why?
Creatine Kinase, MB Form
3
2013
6
0.560
Why?
Foramen Ovale, Patent
2
2014
27
0.540
Why?
Surgical Procedures, Operative
4
2015
67
0.540
Why?
Defibrillators, Implantable
5
2007
66
0.540
Why?
Purinergic P2Y Receptor Antagonists
2
2014
29
0.530
Why?
United States
27
2022
4955
0.520
Why?
Propranolol
3
2008
79
0.520
Why?
Kidney Failure, Chronic
4
2004
201
0.520
Why?
Heart
10
2006
339
0.510
Why?
Randomized Controlled Trials as Topic
12
2021
573
0.510
Why?
Veterans
1
2022
574
0.500
Why?
Tissue Donors
2
2013
121
0.500
Why?
Alloys
2
2020
9
0.500
Why?
Incidence
16
2018
1032
0.490
Why?
Heart Rupture, Post-Infarction
3
2005
4
0.490
Why?
Aortic Valve
3
2022
112
0.480
Why?
Physician-Patient Relations
2
2015
142
0.480
Why?
Fibrinolytic Agents
3
2014
125
0.470
Why?
Vascular System Injuries
1
2015
38
0.470
Why?
Wounds, Penetrating
1
2015
39
0.470
Why?
Tomography, X-Ray Computed
5
2013
1169
0.470
Why?
Ultrasonography, Interventional
7
2013
137
0.460
Why?
Purines
2
2014
37
0.450
Why?
Adenosine A2 Receptor Agonists
1
2014
5
0.450
Why?
Platelet Glycoprotein GPIIb-IIIa Complex
3
2009
31
0.450
Why?
Lisinopril
7
2003
12
0.450
Why?
Anterior Wall Myocardial Infarction
2
2012
7
0.440
Why?
Computer-Assisted Instruction
1
2014
31
0.440
Why?
Metals
2
2011
35
0.440
Why?
Clinical Trials as Topic
9
2012
486
0.440
Why?
Cyclooxygenase 2
8
2008
43
0.440
Why?
Piperazines
2
2012
119
0.430
Why?
Pyrazoles
2
2014
111
0.430
Why?
Anticholesteremic Agents
3
2008
27
0.430
Why?
Blood Vessel Prosthesis Implantation
4
2009
121
0.430
Why?
Mentors
1
2014
55
0.430
Why?
Coronary Vessel Anomalies
3
2017
38
0.430
Why?
Arteries
1
2013
91
0.430
Why?
Atrial Function, Left
1
2013
5
0.420
Why?
Endarterectomy, Carotid
2
2011
62
0.420
Why?
Lipoxins
3
2008
3
0.420
Why?
Imidazoles
9
1990
127
0.410
Why?
Drug Administration Schedule
7
2014
370
0.410
Why?
Cardiac Surgical Procedures
3
2014
314
0.410
Why?
Coronary Aneurysm
2
2007
20
0.410
Why?
Pressure
4
2017
104
0.410
Why?
Drug Eruptions
1
2012
13
0.400
Why?
Rats, Sprague-Dawley
14
2008
1585
0.400
Why?
Physicians
2
2015
232
0.400
Why?
Thiophenes
1
2012
36
0.400
Why?
Rats
19
2011
3292
0.390
Why?
Stroke
3
2013
495
0.390
Why?
Embolism
2
2013
20
0.380
Why?
Quality Assurance, Health Care
4
2012
150
0.380
Why?
Cyclooxygenase Inhibitors
5
2007
38
0.380
Why?
Double-Blind Method
14
2020
708
0.380
Why?
Internet
1
2014
259
0.370
Why?
Diverticulum
1
2011
21
0.370
Why?
Troponin I
1
2011
18
0.370
Why?
Transurethral Resection of Prostate
1
2011
10
0.370
Why?
Intraoperative Complications
4
2020
114
0.370
Why?
Carotid Arteries
1
2011
84
0.360
Why?
Myocytes, Cardiac
5
2011
123
0.360
Why?
Receptors, Adrenergic, beta-2
2
2009
16
0.360
Why?
Embolic Protection Devices
1
2010
6
0.360
Why?
Paclitaxel
1
2011
84
0.360
Why?
Receptors, Opioid, delta
2
2009
25
0.360
Why?
Clinical Competence
4
2013
398
0.350
Why?
Pericardiectomy
2
2024
6
0.350
Why?
Mitral Valve
1
2010
50
0.340
Why?
Endocarditis
1
2010
30
0.340
Why?
Kaplan-Meier Estimate
6
2017
464
0.340
Why?
Adult
47
2019
13584
0.330
Why?
Calcinosis
4
2023
52
0.330
Why?
Anticoagulants
6
2024
256
0.330
Why?
Suction
2
2008
23
0.320
Why?
Sirolimus
2
2009
62
0.320
Why?
Echocardiography, Transesophageal
2
2006
61
0.320
Why?
Hypoglycemic Agents
3
2006
173
0.320
Why?
Heart Valve Prosthesis
3
2022
79
0.310
Why?
Carotid Artery, Common
2
2006
44
0.310
Why?
Myocardial Bridging
1
2008
2
0.310
Why?
Tissue Plasminogen Activator
1
2009
110
0.310
Why?
Heart Failure, Systolic
1
2008
7
0.300
Why?
Aortic Valve Stenosis
3
2022
61
0.300
Why?
Peptides
2
2008
221
0.300
Why?
Azetidines
1
2008
6
0.300
Why?
Creatinine
3
2004
145
0.300
Why?
Consensus
2
2007
160
0.290
Why?
Patient Selection
7
2012
259
0.290
Why?
Exercise Test
10
2002
131
0.290
Why?
Cardiac Output, Low
4
2006
10
0.290
Why?
Heart Septal Defects, Atrial
2
2013
46
0.280
Why?
Animals
28
2022
13124
0.280
Why?
Telemedicine
1
2014
469
0.280
Why?
Drug Therapy, Combination
10
2008
384
0.280
Why?
Vascular Patency
5
2020
83
0.280
Why?
Mitral Valve Insufficiency
3
2007
48
0.270
Why?
Laboratories, Hospital
1
2006
6
0.270
Why?
Aortic Valve Insufficiency
2
2016
24
0.270
Why?
Survival Analysis
11
2010
661
0.270
Why?
Terminology as Topic
3
2013
67
0.270
Why?
Chi-Square Distribution
3
2017
277
0.260
Why?
Echocardiography, Three-Dimensional
1
2006
15
0.260
Why?
Pacemaker, Artificial
1
2007
40
0.260
Why?
Proportional Hazards Models
8
2017
415
0.260
Why?
Bacteremia
1
2007
89
0.250
Why?
Inpatients
2
2018
193
0.250
Why?
Gadolinium DTPA
1
2005
25
0.250
Why?
Chest Pain
3
2006
55
0.250
Why?
Lipopolysaccharides
1
2006
197
0.250
Why?
Nitric Oxide Synthase Type III
6
2008
78
0.240
Why?
Carotid Artery Diseases
1
2005
33
0.240
Why?
Neovascularization, Physiologic
2
2005
68
0.240
Why?
Angina, Stable
2
2016
7
0.240
Why?
Prostaglandins
1
2005
19
0.240
Why?
Europe
8
2019
79
0.240
Why?
Calcium
1
2007
398
0.240
Why?
Arginine Vasopressin
6
2005
13
0.240
Why?
Atrial Fibrillation
4
2021
188
0.240
Why?
Program Evaluation
1
2006
349
0.240
Why?
Pain Management
3
2015
180
0.240
Why?
Dobutamine
6
1999
22
0.230
Why?
Renal Insufficiency
1
2005
110
0.230
Why?
Chemokine CCL2
1
2004
68
0.230
Why?
Dose-Response Relationship, Drug
12
2017
1372
0.230
Why?
Metabolic Clearance Rate
1
2004
69
0.230
Why?
Plasminogen Activator Inhibitor 1
1
2004
6
0.230
Why?
Equipment Design
4
2020
289
0.230
Why?
History, 21st Century
2
2019
56
0.230
Why?
Pericardiocentesis
1
2024
15
0.230
Why?
Angiography
7
2012
128
0.230
Why?
Monocytes
1
2004
127
0.220
Why?
Femoral Artery
4
2019
106
0.220
Why?
History, 20th Century
2
2019
100
0.220
Why?
Secondary Prevention
2
2015
79
0.220
Why?
Artifacts
1
2004
55
0.220
Why?
Reoperation
5
2013
460
0.220
Why?
Reproducibility of Results
6
2016
1199
0.220
Why?
Staphylococcal Infections
1
2007
267
0.220
Why?
Recurrence
7
2016
659
0.220
Why?
Cardiomyopathy, Hypertrophic
1
2004
31
0.220
Why?
Angina Pectoris
4
2020
20
0.220
Why?
Disease Models, Animal
10
2011
1436
0.210
Why?
Nitric Oxide Synthase Type II
4
2008
65
0.210
Why?
Risk
7
2011
324
0.210
Why?
Aged, 80 and over
10
2017
3227
0.210
Why?
Catheterization
4
2019
101
0.210
Why?
Materials Testing
2
2020
56
0.200
Why?
American Heart Association
4
2015
32
0.200
Why?
Hospital Mortality
5
2019
413
0.200
Why?
Anti-Arrhythmia Agents
4
2004
80
0.200
Why?
Cyclosporins
5
1989
11
0.200
Why?
Body Composition
1
2004
327
0.200
Why?
Vasodilation
2
2021
98
0.190
Why?
Constriction, Pathologic
3
2017
94
0.190
Why?
Odds Ratio
4
2016
551
0.190
Why?
Exercise Tolerance
5
1997
42
0.190
Why?
Propanolamines
3
2011
14
0.190
Why?
Retreatment
2
2012
56
0.180
Why?
Heart Valve Prosthesis Implantation
2
2016
85
0.180
Why?
Up-Regulation
4
2011
446
0.180
Why?
Diet, Sodium-Restricted
1
2000
5
0.180
Why?
Enalapril
3
1989
15
0.180
Why?
Hospitalization
5
2011
675
0.180
Why?
Administration, Oral
9
2015
434
0.180
Why?
Cardiomyopathies
9
2003
120
0.170
Why?
United States Department of Veterans Affairs
1
2022
291
0.170
Why?
Logistic Models
5
2018
899
0.170
Why?
Ischemia
1
2021
153
0.170
Why?
Angioplasty
1
2020
20
0.170
Why?
Calcitonin Gene-Related Peptide
2
2009
23
0.170
Why?
Plaque, Atherosclerotic
1
2019
38
0.160
Why?
6-Ketoprostaglandin F1 alpha
3
2008
6
0.160
Why?
Life Style
1
2000
144
0.160
Why?
Heart Rate
7
1993
307
0.160
Why?
Norepinephrine
7
1996
114
0.160
Why?
Specialization
1
2019
46
0.160
Why?
Atherectomy
1
2019
13
0.160
Why?
Cost-Benefit Analysis
2
2014
266
0.160
Why?
Quality Improvement
2
2011
209
0.160
Why?
Atrial Natriuretic Factor
4
1996
25
0.160
Why?
Russia
4
2019
9
0.160
Why?
Radial Artery
1
2019
31
0.160
Why?
Prevalence
5
2018
971
0.160
Why?
Peripheral Arterial Disease
1
2019
69
0.150
Why?
Proto-Oncogene Proteins c-akt
3
2009
156
0.150
Why?
Feasibility Studies
2
2020
391
0.150
Why?
Catheterization, Peripheral
1
2019
48
0.150
Why?
Patient Care Planning
1
2019
66
0.150
Why?
Tachycardia, Ventricular
2
2004
44
0.150
Why?
Emergency Medical Services
1
2019
110
0.150
Why?
Patient Care
1
1998
58
0.150
Why?
Diabetes Mellitus, Type 2
1
2004
519
0.150
Why?
Patient Safety
1
2018
102
0.150
Why?
Multivariate Analysis
6
2016
583
0.150
Why?
Medicare
2
2011
247
0.150
Why?
Fistula
2
1996
26
0.140
Why?
Intra-Aortic Balloon Pumping
2
1994
7
0.140
Why?
Blood Pressure
12
1997
531
0.140
Why?
Education, Medical
1
2019
112
0.140
Why?
Waiting Lists
3
2007
59
0.140
Why?
Adventitia
1
2017
4
0.140
Why?
Cardiac Pacing, Artificial
3
2008
33
0.140
Why?
Education, Medical, Graduate
3
2013
217
0.140
Why?
Curriculum
3
2013
400
0.140
Why?
Renin
5
1996
20
0.140
Why?
Quality of Life
5
2008
852
0.140
Why?
Enoximone
9
1990
10
0.140
Why?
Advisory Committees
2
2014
65
0.140
Why?
Myocardial Revascularization
3
2012
17
0.140
Why?
Substance Withdrawal Syndrome
2
1997
168
0.130
Why?
Epoprostenol
4
1997
24
0.130
Why?
Phosphorylation
6
2008
525
0.130
Why?
Nitric Oxide Synthase
2
2008
74
0.130
Why?
Hypertension, Pulmonary
7
1997
124
0.130
Why?
Propensity Score
1
2017
136
0.130
Why?
Simvastatin
2
2008
29
0.130
Why?
Treatment Failure
4
2018
118
0.130
Why?
Hypertension
6
2011
544
0.130
Why?
Health Personnel
3
2007
247
0.130
Why?
Benzazepines
2
2006
20
0.130
Why?
Renal Insufficiency, Chronic
1
2018
174
0.120
Why?
Phosphodiesterase Inhibitors
4
2007
25
0.120
Why?
Muscle Contraction
1
1996
112
0.120
Why?
Postpericardiotomy Syndrome
1
2015
4
0.120
Why?
Diagnostic Techniques, Cardiovascular
2
2012
4
0.120
Why?
Magnetic Resonance Imaging
1
2022
1556
0.120
Why?
Angioscopy
1
1994
3
0.120
Why?
Verapamil
2
1993
22
0.120
Why?
Cardiomyopathy, Dilated
3
1996
39
0.120
Why?
Age Factors
5
2021
1110
0.120
Why?
Colchicine
1
2015
23
0.120
Why?
Smad3 Protein
1
2014
9
0.120
Why?
Systole
4
2010
72
0.120
Why?
Cholesterol, Dietary
1
2014
19
0.120
Why?
Th2 Cells
1
2014
21
0.120
Why?
Tunica Intima
1
1994
55
0.120
Why?
Cyclic AMP-Dependent Protein Kinases
3
2011
51
0.120
Why?
Patient Care Management
1
2014
18
0.110
Why?
Venous Thrombosis
1
2015
87
0.110
Why?
Area Under Curve
3
2022
179
0.110
Why?
Myocardial Contraction
4
2009
113
0.110
Why?
Receptors, LDL
1
2014
67
0.110
Why?
Disease Progression
5
2008
829
0.110
Why?
Acute Disease
5
2019
373
0.110
Why?
Cardiovascular System
1
2014
52
0.110
Why?
Cohort Studies
6
2022
1452
0.110
Why?
Punctures
3
2019
52
0.110
Why?
Diuretics
4
1998
29
0.110
Why?
Atherosclerosis
2
2014
217
0.110
Why?
Thromboembolism
1
2014
55
0.110
Why?
Dependovirus
1
2014
102
0.110
Why?
Survival Rate
6
2018
909
0.110
Why?
Transfection
1
2014
356
0.110
Why?
Cardiac Output
10
1997
44
0.110
Why?
Remote Consultation
1
2014
28
0.110
Why?
Drug Costs
1
2014
38
0.110
Why?
Quality Indicators, Health Care
2
2011
87
0.110
Why?
Infusions, Intravenous
8
2011
213
0.110
Why?
Arrhythmias, Cardiac
2
2012
94
0.110
Why?
Septal Occluder Device
1
2013
31
0.110
Why?
Case-Control Studies
3
2013
1155
0.110
Why?
Echocardiography, Doppler, Color
1
2013
23
0.110
Why?
Ventricular Function
1
1993
20
0.110
Why?
Pulmonary Edema
1
2013
20
0.100
Why?
Echocardiography, Doppler
2
2016
54
0.100
Why?
Hypertrophy, Left Ventricular
3
2009
41
0.100
Why?
Signal Transduction
3
2009
1624
0.100
Why?
General Surgery
1
2014
108
0.100
Why?
Pulmonary Wedge Pressure
7
1997
26
0.100
Why?
Heparin
2
2024
91
0.100
Why?
Evidence-Based Medicine
2
2011
253
0.100
Why?
Cause of Death
7
2007
151
0.100
Why?
Pleural Effusion
1
2013
38
0.100
Why?
Kidney Diseases
2
2007
213
0.100
Why?
Ultrasonography
3
2010
435
0.100
Why?
Echocardiography
7
2005
400
0.100
Why?
Graft Rejection
8
2009
172
0.100
Why?
Antihypertensive Agents
3
1998
125
0.100
Why?
Image Processing, Computer-Assisted
1
2014
246
0.100
Why?
Embolism, Cholesterol
1
2011
2
0.100
Why?
Sex Factors
5
2022
711
0.100
Why?
Creatine Kinase
2
2003
29
0.100
Why?
Carbazoles
2
2005
16
0.100
Why?
Cardiovascular Surgical Procedures
2
2012
10
0.100
Why?
Exercise
1
1996
516
0.090
Why?
Equipment Failure
3
2008
63
0.090
Why?
Random Allocation
4
2005
289
0.090
Why?
Kidney
4
2005
696
0.090
Why?
Milrinone
1
2011
9
0.090
Why?
Isoenzymes
2
2003
168
0.090
Why?
Death
2
2022
21
0.090
Why?
Insurance Claim Review
1
2011
36
0.090
Why?
Diabetes Complications
3
2011
116
0.090
Why?
Enkephalin, D-Penicillamine (2,5)-
2
2009
3
0.090
Why?
Unnecessary Procedures
1
2011
20
0.090
Why?
Prednisone
3
1989
101
0.090
Why?
Amrinone
2
1987
2
0.090
Why?
Oxygen Consumption
5
1996
191
0.090
Why?
Body Weight
3
2007
517
0.090
Why?
Thrombectomy
1
2011
70
0.090
Why?
Preoperative Care
2
2007
169
0.090
Why?
Cyclooxygenase 2 Inhibitors
2
2007
17
0.090
Why?
Injections, Intra-Arterial
2
2015
13
0.090
Why?
Necrosis
1
2010
174
0.090
Why?
Texas
4
2006
142
0.090
Why?
Surgical Instruments
1
2010
27
0.090
Why?
Disease Management
3
2014
178
0.080
Why?
Cells, Cultured
4
2009
1571
0.080
Why?
Magnetic Resonance Imaging, Cine
1
2010
64
0.080
Why?
Reperfusion Injury
2
2007
86
0.080
Why?
Diatrizoate
1
1989
3
0.080
Why?
Iopamidol
1
1989
2
0.080
Why?
Receptors, Calcitonin Gene-Related Peptide
1
2009
4
0.080
Why?
Ethanolamines
2
1986
13
0.080
Why?
ROC Curve
2
2022
226
0.080
Why?
Endothelium, Vascular
2
2007
251
0.080
Why?
Hyperlipidemias
2
2011
52
0.080
Why?
Drug Administration Routes
1
2008
10
0.080
Why?
Leukotriene B4
1
2008
1
0.080
Why?
Arachidonate 5-Lipoxygenase
1
2008
3
0.080
Why?
Fatal Outcome
2
2007
197
0.080
Why?
Hemostasis, Surgical
1
2008
11
0.080
Why?
Phospholipases A
2
2006
13
0.080
Why?
Phospholipases A2
2
2006
15
0.080
Why?
Patient Transfer
1
2009
95
0.080
Why?
Comorbidity
1
2010
623
0.080
Why?
Meta-Analysis as Topic
1
2008
38
0.080
Why?
Analysis of Variance
2
2008
552
0.070
Why?
Drainage
1
2008
79
0.070
Why?
Sulfonamides
2
2008
126
0.070
Why?
Heart Diseases
3
2006
213
0.070
Why?
Myocardial Reperfusion
1
2007
8
0.070
Why?
Mitogen-Activated Protein Kinase 3
1
2007
49
0.070
Why?
Tetrazoles
1
2007
41
0.070
Why?
Combined Modality Therapy
1
2009
641
0.070
Why?
Dipyridamole
1
2007
9
0.070
Why?
Prostaglandin D2
1
2007
18
0.070
Why?
Prosthesis Failure
2
2012
110
0.070
Why?
Microinjections
2
2018
29
0.070
Why?
Cyclooxygenase 1
1
2007
5
0.070
Why?
Drug Interactions
2
2007
206
0.070
Why?
Nitroso Compounds
1
2006
4
0.070
Why?
Calcium Signaling
1
2007
56
0.070
Why?
Patient Admission
1
2007
76
0.070
Why?
Thoracic Surgery
1
2007
19
0.070
Why?
Mass Screening
2
2004
344
0.070
Why?
PPAR gamma
1
2007
65
0.070
Why?
Enzyme Induction
1
2006
79
0.070
Why?
Anemia, Macrocytic
1
1986
2
0.070
Why?
Deferoxamine
1
1986
9
0.070
Why?
Anemia, Megaloblastic
1
1986
3
0.070
Why?
Biotin
1
2006
46
0.070
Why?
NF-kappa B
1
2008
315
0.070
Why?
Ubiquinone
1
2006
12
0.070
Why?
Hemofiltration
1
2006
7
0.070
Why?
Magnesium
1
2006
36
0.070
Why?
Multicenter Studies as Topic
4
2005
89
0.070
Why?
Electric Countershock
1
2006
30
0.070
Why?
Forecasting
1
2007
147
0.060
Why?
Intracranial Embolism
1
2006
27
0.060
Why?
Diagnosis, Differential
2
2012
1033
0.060
Why?
Patient Education as Topic
2
2000
320
0.060
Why?
Radiology
1
2008
130
0.060
Why?
Heart Atria
1
2006
60
0.060
Why?
Ischemic Preconditioning
1
2005
4
0.060
Why?
Aortic Rupture
1
2006
19
0.060
Why?
Triiodobenzoic Acids
1
2005
9
0.060
Why?
Partnership Practice
1
2005
1
0.060
Why?
Organizational Affiliation
1
2005
2
0.060
Why?
Myocardial Stunning
1
2005
2
0.060
Why?
Health Planning
1
2005
14
0.060
Why?
Foreign Bodies
1
2006
63
0.060
Why?
Metoprolol
1
2005
13
0.060
Why?
Gastrointestinal Hemorrhage
1
2006
80
0.060
Why?
Pyrrolidines
1
2006
67
0.060
Why?
Device Removal
1
2006
85
0.060
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2006
121
0.060
Why?
Iron
1
1986
121
0.060
Why?
Aortic Coarctation
1
2006
34
0.060
Why?
Sensitivity and Specificity
3
2006
861
0.060
Why?
Water-Electrolyte Balance
1
1985
20
0.060
Why?
Accidents, Traffic
1
2006
88
0.060
Why?
Intramolecular Oxidoreductases
1
2005
12
0.060
Why?
Isoxazoles
1
2005
14
0.060
Why?
Prostaglandin-Endoperoxide Synthases
1
2005
24
0.060
Why?
Education, Medical, Continuing
1
2005
71
0.060
Why?
Tetralogy of Fallot
1
2006
83
0.060
Why?
Ephedrine
1
2004
21
0.060
Why?
Regional Blood Flow
1
2004
109
0.060
Why?
Leadership
1
2005
100
0.060
Why?
Membrane Proteins
1
2007
332
0.060
Why?
Hyperhomocysteinemia
1
2004
30
0.060
Why?
Body Surface Area
1
2004
26
0.060
Why?
Polyethylene Terephthalates
1
2004
10
0.060
Why?
Brachiocephalic Trunk
1
2004
6
0.060
Why?
Antioxidants
1
2006
239
0.060
Why?
Ventricular Remodeling
1
2004
61
0.060
Why?
Pregnancy Complications, Cardiovascular
1
2004
29
0.060
Why?
Vascular Endothelial Growth Factor A
1
2005
182
0.060
Why?
Abnormalities, Multiple
1
2006
167
0.060
Why?
Injections, Intravenous
4
2004
137
0.060
Why?
Arteriosclerosis
1
2004
53
0.060
Why?
Swine Diseases
1
2004
6
0.060
Why?
Inflammation
2
2007
610
0.060
Why?
Myocarditis
1
1984
46
0.060
Why?
ATP-Binding Cassette Transporters
1
2004
34
0.060
Why?
Potassium Channels
1
2004
33
0.060
Why?
Enoxaparin
1
2024
31
0.060
Why?
Cytochrome P-450 Enzyme System
1
2005
194
0.050
Why?
Edema
1
2004
69
0.050
Why?
Vasoconstrictor Agents
1
2004
83
0.050
Why?
Immunohistochemistry
2
2005
957
0.050
Why?
Radiography
3
2006
486
0.050
Why?
Glomerular Filtration Rate
2
2018
119
0.050
Why?
Staphylococcus aureus
1
2007
321
0.050
Why?
Sample Size
1
2003
39
0.050
Why?
Heart Aneurysm
1
1983
13
0.050
Why?
Retroperitoneal Space
1
2002
27
0.050
Why?
C-Reactive Protein
1
2003
144
0.050
Why?
Methoxamine
2
1993
4
0.050
Why?
Internship and Residency
1
2008
447
0.050
Why?
Mitral Valve Prolapse
1
1982
3
0.050
Why?
Drug Synergism
3
2007
151
0.050
Why?
Renal Dialysis
1
2003
171
0.050
Why?
Morphine Derivatives
1
2022
27
0.050
Why?
Anesthesia
1
2002
73
0.050
Why?
Pain Clinics
1
2001
4
0.050
Why?
Hospital Units
1
2001
10
0.050
Why?
Hospitals
1
2022
173
0.050
Why?
Dogs
3
1993
186
0.050
Why?
Benchmarking
2
2011
63
0.050
Why?
Nitroglycerin
3
2004
9
0.040
Why?
Comprehensive Health Care
1
2000
9
0.040
Why?
Fluoroscopy
2
1993
49
0.040
Why?
Heart Arrest
1
2002
155
0.040
Why?
Autopsy
1
2000
47
0.040
Why?
Cardiology Service, Hospital
1
2000
15
0.040
Why?
Tissue Scaffolds
1
2020
36
0.040
Why?
Vitamins
1
2000
63
0.040
Why?
Arkansas
2
2016
1984
0.040
Why?
Amyloidosis
2
1991
81
0.040
Why?
Biocompatible Materials
1
2020
66
0.040
Why?
Public Policy
2
2012
35
0.040
Why?
Anti-Inflammatory Agents
2
2015
163
0.040
Why?
Oxidative Stress
1
2004
772
0.040
Why?
Diastole
2
1993
70
0.040
Why?
Peripheral Vascular Diseases
1
2000
21
0.040
Why?
Renal Artery Obstruction
1
2000
22
0.040
Why?
Disease-Free Survival
1
2000
444
0.040
Why?
Hospitals, Public
1
1999
7
0.040
Why?
Placebos
2
1990
87
0.040
Why?
Carotid Stenosis
1
2000
63
0.040
Why?
Syndrome
3
2006
240
0.040
Why?
Morbidity
1
1999
130
0.040
Why?
Risk Adjustment
1
2019
16
0.040
Why?
Mice, Knockout
2
2014
844
0.040
Why?
Adolescent
7
1996
6446
0.040
Why?
Injections, Intralesional
1
2018
31
0.040
Why?
Quality of Health Care
1
2000
184
0.040
Why?
Internationality
1
2018
41
0.040
Why?
Patient Care Team
1
2000
258
0.040
Why?
Losartan
1
1998
27
0.040
Why?
Radiation Dosage
1
2019
162
0.040
Why?
Drug Evaluation
2
1995
28
0.040
Why?
Ventricular Pressure
1
1997
16
0.040
Why?
Administration, Intravenous
1
2018
70
0.040
Why?
Immunoblotting
2
2008
115
0.040
Why?
Health Services Needs and Demand
1
1999
156
0.040
Why?
Respiration
2
1996
99
0.040
Why?
Internal Mammary-Coronary Artery Anastomosis
1
1997
5
0.040
Why?
Biopsy
5
1994
588
0.040
Why?
Radiation Monitoring
1
2017
7
0.040
Why?
Calcium Channel Blockers
1
1997
62
0.040
Why?
International Cooperation
2
2007
47
0.040
Why?
Cardiomegaly
2
1988
39
0.040
Why?
Enzyme-Linked Immunosorbent Assay
2
2008
234
0.030
Why?
Patient Compliance
1
1998
233
0.030
Why?
Ventricular Function, Right
1
1997
39
0.030
Why?
Hormones
2
1987
57
0.030
Why?
Isotonic Contraction
1
1996
1
0.030
Why?
Isometric Contraction
1
1996
21
0.030
Why?
Vascular Resistance
3
1997
56
0.030
Why?
Forearm
1
1996
28
0.030
Why?
Mice
3
2014
5687
0.030
Why?
Socioeconomic Factors
1
1998
591
0.030
Why?
Data Collection
3
2011
280
0.030
Why?
Italy
1
2015
26
0.030
Why?
Delivery of Health Care
1
1998
303
0.030
Why?
Carbon Dioxide
1
1996
95
0.030
Why?
Blood Flow Velocity
1
2015
99
0.030
Why?
Phlebography
1
2015
60
0.030
Why?
Neurotransmitter Agents
1
1995
34
0.030
Why?
Radionuclide Angiography
1
1994
2
0.030
Why?
Tubulin Modulators
1
2015
27
0.030
Why?
Atherectomy, Coronary
1
1994
6
0.030
Why?
Cross-Sectional Studies
1
2020
1608
0.030
Why?
Time
1
2014
28
0.030
Why?
Journal Impact Factor
1
2014
7
0.030
Why?
Kinetics
2
1986
623
0.030
Why?
Models, Cardiovascular
2
2004
21
0.030
Why?
Genetic Vectors
1
2014
128
0.030
Why?
Nervous System Diseases
1
1995
89
0.030
Why?
Fibrosis
1
2014
181
0.030
Why?
Pulmonary Circulation
1
1993
34
0.030
Why?
Monitoring, Physiologic
1
2014
118
0.030
Why?
Learning Curve
1
2013
18
0.030
Why?
Drug Monitoring
1
1993
79
0.030
Why?
Ischemic Attack, Transient
1
2013
55
0.030
Why?
Ultrasonics
1
1993
30
0.030
Why?
Apoptosis
2
2011
1097
0.030
Why?
Jugular Veins
1
1993
34
0.030
Why?
Cardiac Imaging Techniques
1
2012
8
0.030
Why?
Gene Expression Regulation
2
2008
955
0.030
Why?
Epinephrine
1
1993
97
0.030
Why?
Alprostadil
1
1992
10
0.030
Why?
Mice, Inbred C57BL
2
2008
1808
0.020
Why?
Half-Life
2
1998
86
0.020
Why?
Tissue Survival
1
2012
10
0.020
Why?
Obesity
1
2000
1121
0.020
Why?
Myocardial Perfusion Imaging
1
2012
17
0.020
Why?
Smoking
2
2011
507
0.020
Why?
Endocardium
2
1989
7
0.020
Why?
Phosphodiesterase 3 Inhibitors
1
2011
1
0.020
Why?
Tomography, Emission-Computed, Single-Photon
1
2012
52
0.020
Why?
Adrenergic beta-1 Receptor Antagonists
1
2011
6
0.020
Why?
Health Policy
1
2012
146
0.020
Why?
Health Status
1
1993
299
0.020
Why?
In Situ Nick-End Labeling
1
2011
52
0.020
Why?
Adrenergic beta-Agonists
1
1991
43
0.020
Why?
Goals
1
1991
44
0.020
Why?
Recovery of Function
1
2012
191
0.020
Why?
Diagnostic Imaging
1
2012
181
0.020
Why?
Mannitol
1
1990
15
0.020
Why?
Body Water
1
1990
24
0.020
Why?
Critical Care
1
2012
214
0.020
Why?
Dopamine
1
1991
175
0.020
Why?
Vasoconstriction
1
1990
56
0.020
Why?
Graft Survival
1
1991
159
0.020
Why?
Sodium
1
1990
92
0.020
Why?
Blood Volume
1
1990
69
0.020
Why?
Program Development
1
2011
162
0.020
Why?
Adrenergic beta-2 Receptor Antagonists
1
2009
1
0.020
Why?
Adrenergic beta-2 Receptor Agonists
1
2009
3
0.020
Why?
Transplantation, Homologous
1
2009
145
0.020
Why?
Lymphocytes
1
1990
149
0.020
Why?
Liver
1
1994
1132
0.020
Why?
Isoquinolines
1
2008
25
0.020
Why?
Cell Death
1
2009
175
0.020
Why?
Serine
1
2008
37
0.020
Why?
Tyrphostins
1
2008
9
0.020
Why?
Janus Kinases
1
2008
7
0.020
Why?
Physical Exertion
1
1988
48
0.020
Why?
Selection Bias
1
2008
15
0.020
Why?
Electrophoretic Mobility Shift Assay
1
2008
72
0.020
Why?
Pulse
1
1988
13
0.020
Why?
Pennsylvania
3
1993
35
0.020
Why?
Ischemic Preconditioning, Myocardial
1
2007
2
0.020
Why?
Enzyme Activation
1
2008
268
0.020
Why?
Organ Culture Techniques
1
2007
47
0.020
Why?
Bayes Theorem
1
1988
107
0.020
Why?
Creatine Kinase, BB Form
1
2007
1
0.020
Why?
Immunologic Factors
1
2008
111
0.020
Why?
Receptors, Purinergic P1
1
2007
8
0.020
Why?
Survival
1
2007
11
0.020
Why?
Theophylline
1
2007
20
0.020
Why?
Pyridazines
1
1987
11
0.020
Why?
5'-Nucleotidase
1
2007
12
0.020
Why?
Nitriles
1
2007
52
0.020
Why?
Renin-Angiotensin System
1
1987
59
0.020
Why?
Blood Coagulation
1
2007
60
0.020
Why?
Bundle-Branch Block
1
1987
18
0.020
Why?
Models, Chemical
1
2007
64
0.020
Why?
Premedication
1
2007
17
0.020
Why?
Evaluation Studies as Topic
3
1992
107
0.020
Why?
Butadienes
1
2007
49
0.020
Why?
Pain
2
1982
389
0.020
Why?
Drug Combinations
1
2007
127
0.020
Why?
Depression, Chemical
1
1986
14
0.020
Why?
Coenzymes
1
2006
3
0.020
Why?
Stimulation, Chemical
1
1986
30
0.020
Why?
Vasoactive Intestinal Peptide
1
1986
19
0.020
Why?
Heart Function Tests
1
1986
11
0.020
Why?
Protein Kinase Inhibitors
1
2008
204
0.020
Why?
Oncogene Protein v-akt
1
2006
11
0.020
Why?
Fluid Therapy
1
2007
75
0.020
Why?
Phosphoric Monoester Hydrolases
1
2006
20
0.020
Why?
Receptors, Vasopressin
1
2006
23
0.020
Why?
Alanine
1
2006
43
0.020
Why?
Amidines
1
2006
8
0.020
Why?
Lactates
1
1986
30
0.020
Why?
Educational Measurement
1
2008
206
0.020
Why?
Benzylamines
1
2006
15
0.020
Why?
Sulfones
1
2006
24
0.020
Why?
PTEN Phosphohydrolase
1
2006
53
0.020
Why?
Long-Term Care
1
1986
50
0.020
Why?
Research Design
1
2008
353
0.020
Why?
Models, Animal
1
2006
227
0.020
Why?
Magnetic Resonance Angiography
1
2006
71
0.020
Why?
Heart Conduction System
1
2005
23
0.020
Why?
Diabetes Mellitus
1
1989
279
0.020
Why?
Nitric Oxide
1
2007
259
0.020
Why?
Osmotic Pressure
1
1985
11
0.020
Why?
Osmolar Concentration
1
1985
62
0.020
Why?
Safety
1
2005
77
0.020
Why?
Enzyme Inhibitors
1
2007
377
0.020
Why?
Aortography
1
2004
36
0.010
Why?
Anastomosis, Surgical
1
2004
66
0.010
Why?
Glyburide
1
2004
6
0.010
Why?
Scleroderma, Systemic
1
1984
6
0.010
Why?
Ventricular Fibrillation
1
2004
16
0.010
Why?
Anesthesia, Obstetrical
1
2004
39
0.010
Why?
Models, Biological
1
2007
716
0.010
Why?
Statistics as Topic
1
2004
88
0.010
Why?
Vascular Surgical Procedures
1
2006
166
0.010
Why?
Patient Discharge
1
2006
321
0.010
Why?
Transcription Factors
1
2007
565
0.010
Why?
NG-Nitroarginine Methyl Ester
1
2003
18
0.010
Why?
Cesarean Section
1
2004
157
0.010
Why?
Pulmonary Artery
1
1984
154
0.010
Why?
Swine
1
2004
408
0.010
Why?
Endpoint Determination
1
2002
26
0.010
Why?
Thorax
1
1982
15
0.010
Why?
Anxiety Disorders
1
1982
123
0.010
Why?
Popliteal Artery
1
2000
28
0.010
Why?
Iliac Artery
1
2000
34
0.010
Why?
Hospitals, University
1
1999
77
0.010
Why?
Mortality
1
1999
96
0.010
Why?
Brain
1
2006
1323
0.010
Why?
Cross-Over Studies
1
1998
228
0.010
Why?
Pregnancy
1
2004
2451
0.010
Why?
Abdomen
1
1977
75
0.010
Why?
Dyspnea
1
1977
75
0.010
Why?
Physical Examination
1
1977
93
0.010
Why?
Fatigue
1
1977
127
0.010
Why?
Physical Fitness
1
1997
60
0.010
Why?
Actuarial Analysis
1
1996
10
0.010
Why?
Walking
1
1997
100
0.010
Why?
Nitroprusside
1
1992
11
0.010
Why?
Neck
1
1993
99
0.010
Why?
Pilot Projects
1
1995
699
0.010
Why?
Transplantation, Heterotopic
1
1991
7
0.010
Why?
Regression Analysis
1
1991
382
0.010
Why?
Cyclosporine
1
1991
66
0.010
Why?
Cytotoxicity, Immunologic
1
1990
55
0.010
Why?
Histocompatibility Testing
1
1990
12
0.010
Why?
Transplantation, Heterologous
1
1989
75
0.010
Why?
Cell Division
1
1990
291
0.010
Why?
Length of Stay
1
1991
629
0.000
Why?
Atrial Flutter
1
1987
8
0.000
Why?
Bundle of His
1
1987
8
0.000
Why?
Phenotype
1
1990
739
0.000
Why?
Cobalt
1
1986
16
0.000
Why?
Histological Techniques
1
1986
9
0.000
Why?
Endomyocardial Fibrosis
1
1985
3
0.000
Why?
Doxorubicin
1
1986
236
0.000
Why?
Thallium
1
1984
6
0.000
Why?
Radioisotopes
1
1984
17
0.000
Why?
Heart Defects, Congenital
1
1990
602
0.000
Why?
Microcirculation
1
1984
72
0.000
Why?
Radionuclide Imaging
1
1984
116
0.000
Why?
Infant
1
1990
3629
0.000
Why?
Child, Preschool
1
1990
3943
0.000
Why?
Child
1
1990
6910
0.000
Why?
Uretsky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description